Çagla Tükel, PhD, Associate Professor of Microbiology and Immunology at the Lewis Katz School of Medicine at Temple University, was the senior author on a new study published online in the journal Nature Communications that showed a first-of-its-kind therapeutic molecule, a type of monoclonal antibody, shows promise as an immunotherapeutic strategy to break apart communities of harmful bacteria known as biofilms and open the way for antibiotics. These biofilms are notorious for forming on implanted medical devices and on tissues in the body, where they give rise to chronic and sometimes life-threatening infections in patients. Multiple media outlets, including Bioengineer.org, Scienmag, News-Medical.net and ScienceDaily, reported on the findings.
Temple Faculty Physicians is experiencing technical issues with phone lines. If you are experiencing an emergency, please visit your nearest emergency room. If you would like to schedule an appointment with your provider or have general questions or requests, please contact us by using myTempleHealth.
myTempleHealth
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH